Reactions Weekly

, Volume 1187, Issue 1, pp 1–1 | Cite as

Increased haemorrhage risk with idraparinux leads to trial termination

Clinical study
  • 8 Downloads

Keywords

Atrial Fibrillation Warfarin Renal Impairment Acenocoumarol Antagonist Group 

REFERENCE

  1. 1.
    Amadeus Investigators.Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial. Lancet 371: 315-321, No. 9609, 26 Jan 2008Google Scholar

Copyright information

© Adis International limited or Adis Data Information BV 2008

Personalised recommendations